Moneycontrol
you are here: HomeNewsBusiness
Last Updated : Oct 22, 2018 01:43 PM IST | Source: PTI

Unichem gets EIR from USFDA for Pithampur, Roha facilities

The company's API manufacturing facilities have received EIRs from the United States Food and Drug Administration (USFDA) indicating closure of inspections at both the facilities, Unichem Laboratories said in a filing to the BSE.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Drug firm Unichem Laboratories on Monday said its active pharmaceutical ingredient (API) manufacturing units at Pithampur and Roha have received Establishment Inspection Reports (EIR) from the US health regulator.

The company's API manufacturing facilities have received EIRs from the United States Food and Drug Administration (USFDA) indicating closure of inspections at both the facilities, Unichem Laboratories said in a filing to the BSE.

The inspection at Pithampur was conducted by the FDA from July 23, to July 27, 2018 and the inspection at Roha was conducted by the FDA from July 30, to August 3, 2018, it added.

The USFDA releases a copy of the EIR to the establishment that was the subject of an FDA or FDA-contracted inspection when the agency determines the inspection to be closed.

Shares of Unichem Laboratories were Monday trading at Rs 213.50 per scrip on the BSE, up 3.09 percent from its previous close.
First Published on Oct 22, 2018 01:39 pm
More From
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant